
See exactly how BOUT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BOUT and 80,000+ other tickers.
The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--M2 Financial LLC, in conjunction with Capital-FORCE ETF Trust (“Capital-FORCE”), announced today the successful transition of the CapForce IBD® 50 ETF (ticker: FFTY) and CapForce IBD® Breakout Opportunities ETF (ticker: BOUT) to the Capital-FORCE ETF platform. These two legacy strategies, which are licensed from Investor's Business Daily (“IBD”), have become flagship offerings for Capital-FORCE as it launches a focused family of complementary, dynamic rules-based E.

LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--Capital-FORCE announced shareholder approval for the acquisition of Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator IBD 50 ETF (FFTY).

WHEATON, Ill., April 10, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”) announced today the results of the joint special meeting of shareholders of Innovator IBD® Breakout Opportunities ETF (NYSE Arca: BOUT) and Innovator IBD® 50 ETF (NYSE Arca: FFTY) (each a “Target Fund” and collectively, the “Target Funds”) held of April 10, 2026.

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT - Get Free Report) shares traded up 0.8% on Wednesday. The stock traded as high as $40.36 and last traded at $40.36. 1,225 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 7,219 shares. The stock had previously closed at $40.04.

Following on last week's top 10 list, this week's blog focuses on ETFs related to the stocks in the list. For this week, we then screened for ETFs that contained each stock that were also rated 5 (Strong Buy), focusing on the ETF that held the stock in the greatest percentage, then traveling down the lists of ETFs that held it until we found one rated 5. This resulted in a list of Strong Buy 5 rated ETFs that held at least one Strong Buy 5 rated stock as a major holding.